Cardinal Health stock slips after dividend announcement and analyst target update

Cardinal Health Inc. stock (ISIN US14149Y1082) ended the last completed trading session on the New York Stock Exchange at USD 240.49 on September 17, 2026, down 2.71 percent from the prior close according to data on Yahoo Finance. As the stock digests a fresh cash dividend declaration of USD 0.516 per share with an ex-dividend date of October 1, 2026, investors are weighing recent analyst commentary that points to potential upside.

Dividend signal and recent performance

According to Yahoo Finance, Cardinal Health announced a cash dividend of USD 0.516 per share with an ex-dividend date set for October 1, 2026, underscoring management's continued focus on shareholder returns. This payout, when annualized, implies a dividend of about USD 2.06 per share over a full year and offers income-oriented investors an additional yield component on top of the stock's price performance.

The same overview shows Cardinal Health stock closing at USD 240.49 on September 17, 2026, a decline of USD 6.69 or 2.71 percent for that session on the New York Stock Exchange, reflecting a pullback from recent highs.Yahoo Finance For investors, that move comes after a strong run over the past year in which trailing total returns as of September 8, 2026 have outpaced the S&P 500 benchmark, according to the same source.Yahoo Finance

Analyst target points to further upside

A recent technical and valuation overview from Nasdaq Dorsey Wright on September 17, 2026 lists Cardinal Health under the symbol CAH in the Drugs sector with a current price of USD 232.54 and a target of USD 334.00. This target implies upside of roughly 43.6 percent from the USD 232.54 reference price in that roster, suggesting that, in the view of this technical research firm, the shares remain attractive on a pullback.

The same roster describes Cardinal Health as carrying a 4 out of 5 technical rating and notes that the stock is in the top 50 percent of its Drugs-sector matrix, with a long-term relative strength buy signal and consecutive buy signals, and it is characterized as a buy-on-pullback candidate by Nasdaq Dorsey Wright. For investors, that framing means the recent drop of 2.71 percent on September 17, 2026 could be interpreted as part of a broader consolidation phase rather than a fundamental break.

Market context and valuation backdrop

While the precise market capitalization for Cardinal Health on September 17, 2026 is not stated in these sources, earlier trading context indicates that the stock carried a market value near USD 54.60 billion when it traded around USD 232.65 as of September 16, 2026, according to a recent overview on Ad-hoc-news. In that context, a price move from USD 232.65 to USD 240.49 within two sessions corresponds to an increase of roughly 3.4 percent, even after the 2.71 percent pullback on September 17, 2026.

The same Ad-hoc-news article notes that Cardinal Health shares recently traded between a 52-week low and a peak of USD 258.30, so the September 17 closing level of USD 240.49 leaves the stock about 6.8 percent below that recent high. For many investors, the combination of a still-elevated price relative to the 52-week range, a large-cap market value above USD 50 billion and a visible dividend policy forms the core of the current valuation picture.

Stock level remains below recent high

Cardinal Health stock is listed on the New York Stock Exchange under the ticker CAH, and the USD 240.49 closing price on September 17, 2026 serves as the reference level for the latest completed trading day. That price stands noticeably above the levels seen at the start of the trailing period cited by Yahoo Finance but still below the USD 258.30 high mentioned by Ad-hoc-news, which helps frame the stock as consolidating rather than breaking out.

Per the trading snapshot on Yahoo Finance, Cardinal Health shares were flat in after-hours trading at USD 240.49 following the official close at 4:00:02 p.m. Eastern Time on September 17, 2026. That stability after the session's decline indicates that, at least in the immediate aftermath of the dividend announcement and broader market moves, no additional selling pressure materialized in the extended session.

Fact box: Cardinal Health stock key data

More news and analyses on Cardinal Health stock